An interventional study of TIP in Hypospadias Repair, sponsored by Cairo University. Completed at 1 site in Egypt. Open to male participants aged 6 Months to 12 Years. Per ClinicalTrials.gov, last updated 2024-05-14.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
Objective:
To study the effect of tubularizing the urethral plate in DPH in children using 2 different absorbable suture materials, rapidly absorbable, braided 6/0 Vicryl and slowly absorbable monofilament 6/0 Polydioxanone, on complication rates.
Patients and methods:
A prospective, randomized controlled study conducted at the Urology Department, Cairo University Specialized Pediatric Hospital, Abou El Reesh, between September 2021 and September 2022. A total of 69 boys aged between 8 and 120 months with DPH were randomly divided into 2 groups: group(A) Vicryl included 39 boys and group(B) PDS included 30 boys. All boys were uncircumcised with no chordee and were primary repairs. TIP was the surgical technique used by a single pediatric urologist. Follow up was performed in outpatient clinic at 7 days, 1, 3, 6 and 12 months postoperatively. The complications and reoperation rates for both groups were compared.
131 studies on the registry are indexed under Hypospadias; 34 are open to participants now.
This study's enrollment of 69 is close to the median of 68 across 102 interventional studies indexed under Hypospadias.
Browse Hypospadias studies →Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.
Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
TIP hypospadias repair
Procedure: TIP
TIP hypospadias repair
Procedure: TIP
TIP hypospadias repair
complication rate
urethrocutaneous fistula, wound infection, wound dehiscence, overall complications, and reoperation rates
Time frame: one year
This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cairo University